ImportantGeneral Updates

Balaji Amines has announced a board meeting to discuss the financial results for the quarter and half-year.

Balaji Amines Limited logo
Balaji Amines LimitedBALAMINES · Filed with the exchange

The company has received consent to commence manufacturing of ISOPROPYLAMINE (MIPA/DIPA), with trial runs starting soon and commercial production to follow.

This new product line could diversify revenue streams and enhance growth potential.

Read the original filing(PDF)

No comments yet. Be the first.

More from Balaji Amines Limited

All announcements